[Morphologic characteristics of the urothelial bladder tumors]. 2007

R Radosavljević, and J Hadzi Djokić, and M Aćimović, and T Pejcić, and C Tulić, and Z Dzamić
Institut za urologiju i nefrologiju, KC Srbije, Beograd.

Cancer of the urinary bladder is the fourth most common cancer in men and the ninth in women. Approximately 67,000 people (50,000 males and 17,000 females) develop bladder cancer each year in the United States, and 13,750 individuals (9,630 males and 4,120 females) are expected to die from it. In the showing of the morphologic characteristics of the tumors, authors underlining the increasing of the incidence, pathogenesis, premalignant lesions and the risk factors of disease.

UI MeSH Term Description Entries
D008297 Male Males
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Radosavljević, and J Hadzi Djokić, and M Aćimović, and T Pejcić, and C Tulić, and Z Dzamić
March 2010, Menopause (New York, N.Y.),
R Radosavljević, and J Hadzi Djokić, and M Aćimović, and T Pejcić, and C Tulić, and Z Dzamić
January 1992, Child nephrology and urology,
R Radosavljević, and J Hadzi Djokić, and M Aćimović, and T Pejcić, and C Tulić, and Z Dzamić
September 1998, Bulletin du cancer,
R Radosavljević, and J Hadzi Djokić, and M Aćimović, and T Pejcić, and C Tulić, and Z Dzamić
November 2013, Urologic oncology,
R Radosavljević, and J Hadzi Djokić, and M Aćimović, and T Pejcić, and C Tulić, and Z Dzamić
January 1994, Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique,
R Radosavljević, and J Hadzi Djokić, and M Aćimović, and T Pejcić, and C Tulić, and Z Dzamić
March 1973, Zentralblatt fur Chirurgie,
R Radosavljević, and J Hadzi Djokić, and M Aćimović, and T Pejcić, and C Tulić, and Z Dzamić
November 2002, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie,
R Radosavljević, and J Hadzi Djokić, and M Aćimović, and T Pejcić, and C Tulić, and Z Dzamić
January 1988, Annales d'urologie,
R Radosavljević, and J Hadzi Djokić, and M Aćimović, and T Pejcić, and C Tulić, and Z Dzamić
December 1997, Pathologie-biologie,
R Radosavljević, and J Hadzi Djokić, and M Aćimović, and T Pejcić, and C Tulić, and Z Dzamić
January 1982, Carcinogenesis,
Copied contents to your clipboard!